The Epidemic of Thyroid Cancer: Is It Real?
Physicians and the public are concerned and confused about the epidemic of thyroid cancer. Physicians are frequently uncertain about the appropriate evaluation of thyroid nodules and there is uncertainty about the appropriate extent of thyroid surgery for well-differentiated thyroid cancer. Learn more about this epidemic from Robert Udelsman, M.D.
Primary Care Physicians, Dentists, Otolaryngologists, Gastroenterologists, Radiologists, Medical Oncologists, Oral Maxillofacial Surgeons, Surgeons, Pathologists, Hospitalists, and Physician Assistants.
- Identify which thyroid nodules should be biopsied and recognize the appropriate extent of thyroid surgery.
- Explain the possible causes of the thyroid cancer epidemic.
Robert Udelsman, M.D., MBA, FACS, FACE
Director, Endocrine Neoplasia Institute
Chief of Endocrine Surgery
Disease Team Director, Endocrine Neoplasia
Miami Cancer Institute
Robert Udelsman, M.D., faculty of this educational activity, has no relevant financial relationship(s) with ineligible companies* to disclose and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have relevant financial relationships to disclose with ineligible companies* as indicated below.
Guilherme Rabinowits, M.D., indicated that he is a consultant with Pfizer, Merck, Sanofi, Castel, Lighthouse, EMD Serono and Regeneron and a shareholder with Regeneron and Syros Pharmaceuticals.
Geoffrey Young, M.D., indicated that neither he nor his spouse/partner has relevant financial relationships with commercial interest companies.
All of the relevant financial relationships listed for these individuals have been mitigated.
Other contributors involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose with ineligible companies*.
*Ineligible companies - Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 0.25 AMA PRA Category 1 Credit™
- 0.25 General certificate of attendance
This site is supported on the most recent stable releases of the following browsers:
This site is supported on the following mobile devices:
If you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.